Creatv has developed a proprietary LifeTracDx Liquid Biopsy to collect cancer associated cells from blood of cancer patients with solid tumors. The blood tests are applicable to a) screening for pan cancer, b) determine residual disease, c) detect cancer recurrence, d) provide companion diagnostics without tissue, e) provide prognosis at any time, f) predict treatment response to new therapy within one treatment cycle, g) identify drug resistance, and h) provide copious unfragmented tumor DNA. These tests can assist drug development, and save and improve lives.
Additional Info
Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?
Yes